ATLANTA, GA – – (Globe Newswire – May 24, 2023) – – Holzer & Holzer, LLC is investigating whether Integra LifeSciences Holdings Corporation (“Integra,” or the “Company”) (NASDAQ: IART) complied with federal securities laws. On May 23, 2023, Integra disclosed that the Company was recalling all products manufactured in its Boston facility that were distributed between March 1, 2018 and May 22, 2023, due to concerns over the level of endotoxins in its products. As a result of the global recall and manufacturing stoppage, the Company expects to incur an impairment charge of approximately $22 million. Following this news, the price of the Company’s stock dropped.
If you purchased Integra stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at email@example.com or Joshua Karr, Esq. at firstname.lastname@example.org, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/Integra/ to discuss your legal rights.